Chemoinformaics analysis of 2-O-methylisohemigossylic acid lactone
| Molecular Weight | 272.3 | nRot | 2 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 15 |
| Exact Molecular Weight | 272.105 | nRing | 3 |
| Solubility: LogS | -4.37 | nHRing | 1 |
| Solubility: LogP | 4.333 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 40.5967 |
| nHD | 1 | BPOL | 20.3913 |
| QED | 0.714 |
| Synth | 3.343 |
| Natural Product Likeliness | 0.986 |
| NR-PPAR-gamma | 0.893 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.307 |
| HIA | 0.1 |
| CACO-2 | -4.899 |
| MDCK | 0.00000828 |
| BBB | 0.009 |
| PPB | 0.895092 |
| VDSS | 0.785 |
| FU | 0.109626 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.954 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.514 |
| CYP2c9-inh | 0.346 |
| CYP2c9-sub | 0.805 |
| CYP2d6-inh | 0.313 |
| CYP2d6-sub | 0.48 |
| CYP3a4-inh | 0.101 |
| CYP3a4-sub | 0.208 |
| CL | 9.236 |
| T12 | 0.498 |
| hERG | 0.004 |
| Ames | 0.567 |
| ROA | 0.717 |
| SkinSen | 0.861 |
| Carcinogencity | 0.542 |
| EI | 0.855 |
| Respiratory | 0.748 |
| NR-Aromatase | 0.805 |
| Antiviral | Yes |
| Prediction | 0.681532 |